首页> 外文期刊>Cardiovascular therapeutics >Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
【24h】

Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials

机译:Allopurinol和内皮功能:随机对照试验的Meta分析进行系统综述

获取原文
获取原文并翻译 | 示例
           

摘要

Summary Aim Oxidative stress and endothelial dysfunction are two inter‐related conditions commonly seen in patients with cardiovascular risk factors. The enzyme, xanthine oxidase, is an important contributor to these phenomena but to a variable degree in different patient populations. This meta‐analysis will summarize the effect of allopurinol, an established xanthine oxidase inhibitor, on endothelial function among patients with different comorbidities. Methods Medline Complete, PubMed, ProQuest, ClinicalKey, Wiley Online Library, and Cochrane Central Register of Controlled Trials were searched till July 29, 2017. Meta‐analysis was planned for randomized controlled trials ( RCT s) that investigated allopurinol effects on endothelial function. A random effect model was used to calculate the standardized mean difference (with 95% confidence intervals: CI ) as an estimate of effect size. Heterogeneity was quantified by four types of information: Q statistics, I 2 statistic, Tau‐squared ( T 2 ), and Tau ( T ). Results Thirty eligible studies were identified; 12 were included in the final analysis and subdivided among 3 patient’s groups: patients with chronic heart failure ( CHF ; 197 patients), patients with chronic kidney disease ( CKD ; 183 patients), and patients with type 2 diabetes mellitus ( DM ; 170 patients). Allopurinol was found to have a statistically significant benefit on endothelial function in patients with CHF and CKD but not in type 2 DM . The standardized mean differences and CI in the three patient’s groups were 0.776 (0.429, 1.122), 0.350 (0.009, 0.690), and 1.331 (?0.781, 3.444), respectively. Conclusion Allopurinol has an antioxidant property that might partially reverse endothelial dysfunction in patients with certain comorbidities. The importance of this property and the magnitude of the beneficial effect are likely to be related to the relative contribution of xanthine oxidase into the oxidative stress associated with different underlying pathologies.
机译:发明内容目标氧化应激和内皮功能障碍是心血管危险因素患者常见的两个与相关条件。酶黄嘌呤氧化酶是这些现象的重要因素,但在不同患者群体的可变程度上。该荟萃分析将总结Allopurinol,一个已建立的黄嘌呤氧化酶抑制剂,在不同合并症患者的内皮功能上的作用。方法采用Medline完成,PubMed,Proquest,ClingaryKey,Wiley在线图书馆和Cochrane中央登记的受控试验中,直到2017年7月29日。计划进行随机对照试验(RCT S),用于研究对内皮酚含量的影响。随机效果模型用于计算标准化平均差异(具有95%置信区间:CI)作为效果大小的估计。通过四种类型的信息量化了异质性:Q统计,I 2统计,TAU平方(T 2)和TAU(T)。结果确定了三十个合格的研究; 12被列入最终分析和细分3例患者组中:慢性心力衰竭(CHF; 197名患者),慢性肾病(CKD; 183名患者)和2型糖尿病患者(DM; 170名患者)。发现Allopurinol对CHF和CKD患者的内皮功能有统计学显着的益处,但不含2 DM。三个患者组中的标准化平均差异和CI分别为0.776(0.429,122),0.350(0.009,0.690)和1.331(Δ0.781,3.444)。结论Allopurinol具有抗氧化性能,可能部分地逆转患者内皮功能障碍。这种性质的重要性和有益效果的幅度可能与黄嘌呤氧化酶的相对贡献有关与与不同潜在的病理相关相关的氧化应激的相关贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号